CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
VoluFaTE aims to revolutionize tissue engineering by controlling cell volume in 3D tissues, using innovative microgel technology. This approach targets improved healing of cartilage defects and enhances the responsiveness of engineered tissues.
Engineering living tissues is expected to revolutionize pharmacological screenings, fundamental biological studies, cruelty-free meat production, and engineered organ replacements.
Historically, the functional performance of the living cells within engineered tissues is controlled exclusively via chemical (e.g., growth factors or cell binding peptides) or mechanical (e.g., stiffness/stress relaxation) properties of the biomaterial.
All these approaches are united in their shared grand limitation…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Boston
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
